Marc Antoine Aimé | Regen Lab

RegenPRP™ : Androgenetic alopecia | Ho A, Sukhdeo K, Lo Sicco K, Shapiro J.

par Marc Antoine Aimé | Jan 28, 2025 | Clinical Study Alopecia

Androgenetic alopecia Ho A, Sukhdeo K, Lo Sicco K, Shapiro J. Trichologic response of platelet-rich plasma in androgenetic alopecia is maintained during combination therapy. OBJECTIVE Evaluate the efficacy and safety of RegenPRP™ mesotherapy in combination with other...

RegenPRP™ + ATS : Chronic Wounds | Kontopodis, N., et al. | Rainys, D., et al.

par Marc Antoine Aimé | Jan 28, 2025 | Clinical Study Wound Care

Chronic Wounds : 1 Diabetic Foot Ulcers | 2 Leg ulcers 1 Kontopodis, N., et al. | 2 Rainys, D., et al. Diabetic Foot Ulcers (DFU) Effectiveness of RegenPRP® fibrin clot to enhance healing of DFU in patients with concomitant peripheral arterial disease (PAD) and...

RegenPRP™ : Achilles tendinopathies | Salini 2015

par Marc Antoine Aimé | Jan 28, 2025 | Clinical Study Tendinopathies

Achilles tendinopathies Salini 2015 Platelet Rich Plasma Therapy in Non-insertional Achilles Tendinopathy: The Eicacy is Reduced in 60-years Old People Compared to Young and Middle-Age Individuals. OBJECTIVE Evaluate the use of RegenPRP™ for the treatment of...

REGENPRP™-HA COMBINATION : Facial appearance | Hersant B. et al | Micheels P.

par Marc Antoine Aimé | Jan 28, 2025 | Clinical Study Dermal PRP-HA

REGENPRP™-HA COMBINATION : Facial appearance Hersant B. et al | Micheels P. A significant breakthrough in facial rejuvenation has been highlighted in a prospective study published in the Journal of the American Academy of Dermatology in 2017. Conducted by Hersant et...

LICHEN SCLEROSUS | Chernova 2016

par Marc Antoine Aimé | Jan 28, 2025 | Clinical Study gynecology

LICHEN SCLEROSUS CHERNOVA 2016 Experience in management of patients with lichen sclerosus and HPV infection of the vulva. Lichen sclerosus (LS) is a chronic inflammatory dermatitis that creates patchy, white skin that appears thinner than normal. It usually affects...

« Entrées précédentes

Entrées suivantes »



RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.



RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.



RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.



RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).



Hyaluronic Acid

Coming Soon



Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EU-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.



Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.



Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.